Negative finding on inconclusive BSE test result
Bio-Rad Life Science
BSE assay
Bio-Rad says it is pleased that its test has performed as expected, screening more than 121,000 samples as part of USDA's enhanced BSE surveillance programme
The US Department of Agriculture (USDA) announced in November 2004 that confirmatory testing procedures have been completed on inconclusive tissue samples that were sent to the national BSE reference laboratory (National Veterinary Services Laboratories, NVSL) on 18 November 2004.
These confirmatory results indicate that the sample in question is negative for BSE.
Bio-Rad is pleased that its test has performed as expected, screening more than 121,000 samples as part of USDA's enhanced BSE surveillance programme.
The test is designed to be extremely sensitive so that it will detect any sample with the potential of being positive.
By using Bio-Rad's rapid screening test, the USDA has been able to streamline BSE test processing in its efforts to determine if mad cow disease is present in the U.S.
As USDA noted, "Screening tests are often used in both human and animal health, and inconclusives are not unexpected".
"These tests cast a very wide net and many end up negative during further testing".
Bio-Rad Laboratories has extensive experience providing BSE tests to 27 countries including Japan, Germany, the United Kingdom, Canada and the United States.
More than 27 million cattle worldwide have been screened using the Bio-Rad BSE assay.
More stories
Proposal to acquire BioSource International
Bio-Rad Laboratories has made a proposal to BioSource International to acquire all of its outstanding shares for US$8.50 per share in cash
Comments on positive confirmation of BSE in USA
The Bio-Rad test is a critical factor in the success of the USDA surveillance programme because it identifies even the most difficult-to-detect abnormal prions
Bio-Rad purchases MJ GeneWorks
MJ Research is a life science company that specialises in premium instruments and consumables used in biological research, including thermal cycling instrumentation and reagents used to amplify DNA
Bio-Rad purchases the assets of Hematronix
Bio-Rad will maintain Hematronix's operations in Plano, Texas, while research and development, manufacturing and distribution activities will continue in Benicia, California.
Alberta selects Bio-Rad rapid BSE test
Bio-Rad Laboratories reports that the province of Alberta in Canada has chosen its automated TeSeE test for use in its enhanced BSE (bovine spongiform encephalopathy) surveillance programme


